Investors buy Warner Chilcott in $3 billion acquisition deal

Share this article:
An investor group led by JPMorgan Chase and Credit Suisse
First Boston has acquired drug maker Warner Chilcott in a $3 billion
deal.
The drug company maintains joint headquarters in Northern Ireland
and Rockaway, N.J., with most of its 1,000 employees in the U.S.
Warner Chilcott is the maker of several products in the oral contraceptives, hormone replacement therapy, urology and dermatology markets.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.